Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aspen Aerogels (ASPN) Research & Development (2016 - 2025)

Historic Research & Development for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $2.5 million.

  • Aspen Aerogels' Research & Development fell 4567.63% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 1520.32%. This contributed to the annual value of $18.0 million for FY2024, which is 1035.71% up from last year.
  • Per Aspen Aerogels' latest filing, its Research & Development stood at $2.5 million for Q3 2025, which was down 4567.63% from $3.8 million recorded in Q2 2025.
  • Aspen Aerogels' Research & Development's 5-year high stood at $4.7 million during Q3 2022, with a 5-year trough of $2.4 million in Q1 2021.
  • In the last 5 years, Aspen Aerogels' Research & Development had a median value of $4.1 million in 2023 and averaged $3.9 million.
  • As far as peak fluctuations go, Aspen Aerogels' Research & Development skyrocketed by 7044.84% in 2022, and later crashed by 4567.63% in 2025.
  • Over the past 5 years, Aspen Aerogels' Research & Development (Quarter) stood at $3.3 million in 2021, then rose by 26.68% to $4.2 million in 2022, then fell by 2.91% to $4.1 million in 2023, then rose by 8.1% to $4.4 million in 2024, then plummeted by 43.38% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $3.8 million for Q2 2025, and $4.3 million during Q1 2025.